BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37351703)

  • 1. Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach.
    Kong SH; Kurokawa Y; Yook JH; Cho H; Kwon OK; Masuzawa T; Lee KH; Matsumoto S; Park YS; Honda H; Ryu SW; Ishikawa T; Kang HJ; Nabeshima K; Im SA; Shimokawa T; Kang YK; Hirota S; Yang HK; Nishida T
    Gastric Cancer; 2023 Sep; 26(5):775-787. PubMed ID: 37351703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.
    Kurokawa Y; Yang HK; Cho H; Ryu MH; Masuzawa T; Park SR; Matsumoto S; Lee HJ; Honda H; Kwon OK; Ishikawa T; Lee KH; Nabeshima K; Kong SH; Shimokawa T; Yook JH; Doki Y; Im SA; Hirota S; Hahn S; Nishida T; Kang YK
    Br J Cancer; 2017 Jun; 117(1):25-32. PubMed ID: 28535156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Neoadjuvant Imatinib to Facilitate Minimally Invasive Resection of Gastric Gastrointestinal Stromal Tumors.
    Li GZ; Fairweather M; Raut CP; Wang J
    Ann Surg Oncol; 2022 Oct; 29(11):7104-7113. PubMed ID: 35624191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally Invasive Resection of Large Gastric Gastrointestinal Stromal Tumors.
    Gertsen EC; van Boxel GI; Brosens LAA; Ruurda JP; van Hillegersberg R
    Dig Surg; 2020; 37(6):441-446. PubMed ID: 32980837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resection of a Huge Gastrointestinal Stromal Tumor of the Stomach Following Neoadjuvant Chemotherapy with Imatinib].
    Sato Y; Karasawa H; Aoki T; Imoto H; Tanaka N; Watanabe K; Abe T; Nagao M; Ohnuma S; Musha H; Takahashi M; Motoi F; Naitoh T; Ishioka C; Unno M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2216-2218. PubMed ID: 28133274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study.
    Qi J; Liu HL; Ren F; Liu S; Shi W; Liu WH; Cai GQ; Liao GQ
    World J Surg Oncol; 2020 Apr; 18(1):70. PubMed ID: 32264886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GISTs) is Effective and Safe: Results from a Prospective Single-Center Study with 108 Patients.
    van der Burg SJC; van de Wal D; Roets E; Steeghs N; van Sandick JW; Kerst M; van Coevorden F; Hartemink KJ; Veenhof XAAFA; Koenen AM; Ijzerman N; van der Graaf WTA; Schrage YM; van Houdt WJ
    Ann Surg Oncol; 2023 Dec; 30(13):8660-8668. PubMed ID: 37814179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center.
    Renberg S; Zhang Y; Karlsson F; Bränström R; Åhlen J; Jalmsell L; Linder-Stragliotto C; Haglund de Flon F; Papakonstantinou A
    Int J Cancer; 2022 Sep; 151(6):906-913. PubMed ID: 35478315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
    Yang W; Liu Q; Lin G; Zhang B; Cao H; Zhao Y; Xia L; Feng F; Xiong Z; Hu J; Ye Y; Tao K; Zhang P
    J Surg Oncol; 2021 Dec; 124(7):1128-1135. PubMed ID: 34324197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic Complete Response in a Large Gastric GIST: Using Molecular Markers to Achieve Maximal Response to Neoadjuvant Imatinib.
    Brown JB; Pai RK; Burgess MA; Chennat J; Zureikat AH
    J Natl Compr Canc Netw; 2018 Dec; 16(12):1424-1428. PubMed ID: 30545989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal stromal tumors: case series of 29 patients defining the role of imatinib prior to surgery.
    Shrikhande SV; Marda SS; Suradkar K; Arya S; Shetty GS; Bal M; Shukla PJ; Goel M; Mohandas KM
    World J Surg; 2012 Apr; 36(4):864-71. PubMed ID: 22350473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant Imatinib Therapy Followed by Intersphincteric Resection for Low Rectal Gastrointestinal Stromal Tumors.
    Kaneko M; Nozawa H; Emoto S; Murono K; Sasaki K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Kawai K; Watanabe T
    Anticancer Res; 2017 Sep; 37(9):5155-5160. PubMed ID: 28870948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open transanal resection of low rectal stromal tumor following neoadjuvant therapy of imatinib mesylate: Report of 11 cases and review of literature.
    Sun Q; Su N; Li X; Hu Z; Wang W
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):123-128. PubMed ID: 31957191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indications for pre- and postoperative treatment with imatinib for gastrointestinal stromal tumors].
    Heger U; Weitz J; Lordick F
    Chirurg; 2008 Jul; 79(7):630-7. PubMed ID: 18548219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study.
    Hølmebakk T; Hompland I; Bjerkehagen B; Stoldt S; Bruland ØS; Hall KS; Boye K
    Ann Surg Oncol; 2018 May; 25(5):1133-1139. PubMed ID: 29435684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Factors After Neoadjuvant Imatinib for Newly Diagnosed Primary Gastrointestinal Stromal Tumor.
    Cavnar MJ; Seier K; Gönen M; Curtin C; Balachandran VP; Tap WD; Antonescu CR; Singer S; DeMatteo RP
    J Gastrointest Surg; 2021 Jul; 25(7):1828-1836. PubMed ID: 33169327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of neoadjuvant treatment on rectal gastrointestinal stromal tumors.
    Cheong C; Kang J; Min BS; Kim NK; Ahn JB; Lee KY
    PLoS One; 2022; 17(9):e0270887. PubMed ID: 36084094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal Stromal Tumors of the Stomach and Esophagus.
    Theiss L; Contreras CM
    Surg Clin North Am; 2019 Jun; 99(3):543-553. PubMed ID: 31047041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing prognostic factors of long-term survival after surgery for colorectal gastrointestinal stromal tumours.
    Yang S; Maspero M; Holubar SD; Hull TL; Lightner AL; Valente MA; Gorgun E; Kalady MF; Steele SR; Liska D
    Colorectal Dis; 2023 Dec; 25(12):2325-2334. PubMed ID: 37876119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic resection for imatinib-resistant recurrent tumors of gastric gastrointestinal stromal tumors: A case report.
    Sekiguchi N; Takahashi T; Nakajima K; Kurokawa Y; Saito T; Yamamoto K; Yamashita K; Tanaka K; Makino T; Eguchi H; Doki Y
    Asian J Endosc Surg; 2022 Jul; 15(3):638-641. PubMed ID: 35108756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.